Yohimbine, an alpha2 adrenergic receptor antagonist, effectively raises norepinephrine levels and enhances fat loss. The fat loss effect is due to both appetite suppression (via norepinephrine) and increasing fatty acid mobilization.
Some studies show that yohimbine causes anxiety. It does not appear to have the same cardiovascular risks as ephedra though, since it also acts as a vasodilator.